Clinical trials
Phase 3 Hepatitis C trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 2 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 3 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 5 |
| Gilead Sciences | 5 |
| Janssen Pharmaceutical K.K. | 4 |
| Boehringer Ingelheim | 3 |
| Tanabe Pharma Corporation | 2 |
| Astellas Pharma Inc | 1 |
| Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 21 |
| Hepatitis C, Chronic | 5 |
| Virus Diseases | 2 |
| Communicable Diseases | 1 |
| Digestive System Diseases | 1 |
| Hepatitis | 1 |
| Hepatitis, Viral, Human | 1 |
| Liver Cirrhosis | 1 |
| Liver Diseases | 1 |
| RNA Virus Infections | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.